Relationship between etonogestrel level and BMI in women using the contraceptive implant for more than 1 year
- PMID: 26577754
- DOI: 10.1016/j.contraception.2015.11.005
Relationship between etonogestrel level and BMI in women using the contraceptive implant for more than 1 year
Abstract
Progestin-only contraceptive methods, including the 3-year, single-rod etonogestrel (ENG) implant, may be preferred for obese women to avoid additional estrogen-related thrombosis risk; however, whether obese women receive an ENG sufficient dose to suppress ovulation is understudied. Our analysis expands on the limited information currently available by studying ENG levels related to body mass index (BMI) in a community sample of primarily Hispanic women. This cross-sectional, descriptive study of 52 long-term implant users found comparable ENG levels across a wide BMI range (p=.1). These results further support that ENG levels are independent of BMI through 3 years of implant use and are thus reassuring that ENG implants will be effective for women of all BMIs.
Trial registration: ClinicalTrials.gov NCT01855620.
Keywords: Contraception; Etonogestrel; Implant; Obesity.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users.Contraception. 2019 Jul;100(1):37-41. doi: 10.1016/j.contraception.2019.03.045. Epub 2019 Apr 10. Contraception. 2019. PMID: 30980827 Free PMC article.
-
The association between BMI and continuity of etonogestrel (ENG)-releasing implant.Int J Gynaecol Obstet. 2024 Oct;167(1):254-258. doi: 10.1002/ijgo.15590. Epub 2024 May 7. Int J Gynaecol Obstet. 2024. PMID: 38712353
-
Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.Am J Obstet Gynecol. 2017 Jun;216(6):586.e1-586.e6. doi: 10.1016/j.ajog.2017.01.036. Epub 2017 Jan 29. Am J Obstet Gynecol. 2017. PMID: 28147241 Free PMC article.
-
Subdermal contraceptive implants.J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):223-6. doi: 10.1016/0960-0760(95)00051-z. J Steroid Biochem Mol Biol. 1995. PMID: 7626459 Review.
-
Association of Etonogestrel-Releasing Contraceptive Implant with Reduced Weight Gain in an Exclusively Breastfed Infant: Report and Literature Review.Breastfeed Med. 2016 May;11(4):203-6. doi: 10.1089/bfm.2016.0017. Epub 2016 Mar 31. Breastfeed Med. 2016. PMID: 27032034 Free PMC article. Review.
Cited by
-
Long-acting reversible contraception with etonogestrel implants in female macaques (Macaca mulatta and Macaca fascicularis).Front Vet Sci. 2024 Jan 8;10:1319862. doi: 10.3389/fvets.2023.1319862. eCollection 2023. Front Vet Sci. 2024. PMID: 38260208 Free PMC article.
-
Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users.Contraception. 2019 Jul;100(1):37-41. doi: 10.1016/j.contraception.2019.03.045. Epub 2019 Apr 10. Contraception. 2019. PMID: 30980827 Free PMC article.
-
Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users.Obstet Gynecol. 2019 Apr;133(4):783-794. doi: 10.1097/AOG.0000000000003189. Obstet Gynecol. 2019. PMID: 30870275 Free PMC article.
-
Safety and Benefits of Contraceptives Implants: A Systematic Review.Pharmaceuticals (Basel). 2021 Jun 8;14(6):548. doi: 10.3390/ph14060548. Pharmaceuticals (Basel). 2021. PMID: 34201123 Free PMC article. Review.
-
Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.Pharmacol Ther. 2021 Jun;222:107789. doi: 10.1016/j.pharmthera.2020.107789. Epub 2020 Dec 13. Pharmacol Ther. 2021. PMID: 33316287 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources